AOXG Stock - Aoxing Pharmaceutical Company, Inc.
Unlock GoAI Insights for AOXG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2023 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | $32.33M | $25.48M | $12.74M |
| Gross Profit | N/A | N/A | $24.55M | $19.79M | $5.81M |
| Gross Margin | N/A | N/A | 75.9% | 77.7% | 45.6% |
| Operating Income | $-7,300 | $-14,820 | $6.23M | $8.70M | $-3,335,000 |
| Net Income | $55,238 | $-14,825 | $2.06M | $5.50M | $-8,216,000 |
| Net Margin | N/A | N/A | 6.4% | 21.6% | -64.5% |
| EPS | $0.00 | $-0.00 | $0.03 | $0.09 | $-0.16 |
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.
Visit WebsiteEarnings History & Surprises
AOXGEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2017 | May 15, 2017 | — | $0.00 | — | — |
Q1 2017 | Feb 14, 2017 | — | $-0.00 | — | — |
Q4 2016 | Nov 14, 2016 | — | $0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.01 | — | — |
Q1 2016 | Mar 31, 2016 | — | $0.01 | — | — |
Q4 2015 | Dec 31, 2015 | — | $0.03 | — | — |
Q3 2015 | Sep 30, 2015 | — | $0.02 | — | — |
Q2 2015 | Jun 30, 2015 | — | $0.02 | — | — |
Q1 2015 | Mar 31, 2015 | — | $0.01 | — | — |
Q4 2014 | Dec 31, 2014 | — | $0.01 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.00 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.04 | — | — |
Q1 2014 | Mar 31, 2014 | — | $-0.04 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.04 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-0.04 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-0.08 | — | — |
Q1 2013 | Mar 31, 2013 | — | $-0.05 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-0.06 | — | — |
Q3 2012 | Sep 30, 2012 | — | $-0.01 | — | — |
Q2 2012 | Jun 30, 2012 | — | $-0.08 | — | — |
Latest News
Frequently Asked Questions about AOXG
What is AOXG's current stock price?
What is the analyst price target for AOXG?
What sector is Aoxing Pharmaceutical Company, Inc. in?
What is AOXG's market cap?
Does AOXG pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AOXG for comparison